Chiesi USA

Chiesi USA products

B

• Bethkis®

  • Generic: tobramycin inhalation solution

  • Indication: maintenance therapy for Pseudomonas aeruginosa infection in cystic fibrosis patients

• Bronchitol® (Note: delisted as of 2025)

  • Generic: mannitol dry powder inhalation

  • Indication: airway clearance in cystic fibrosis

C

• Cardene IV®

  • Generic: nicardipine intravenous infusion

  • Indication: short-term management of hypertension (hospital use)

• Cleviprex®

  • Generic: clevidipine injectable emulsion

  • Indication: rapid blood pressure control in acute settings (perioperative or hypertensive emergencies)

• Curosurf®

  • Generic: poractant alfa intratracheal suspension

  • Indication: surfactant replacement therapy for neonatal respiratory distress syndrome

E

• Elfabrio®

  • Generic: pegunigalsidase alfa

  • Indication: enzyme replacement therapy for Fabry disease

F

• Ferriprox®

  • Generic: deferiprone

  • Indication: chelation therapy for secondary iron overload

• Filsuvez®

  • Generic: birch triterpenes topical gel

  • Indication: treatment of wounds in epidermolysis bullosa (EB)

K

• Kengreal®

  • Generic: cangrelor injection

  • Indication: intravenous antiplatelet therapy to reduce thrombotic events during percutaneous coronary intervention (PCI)

L

• Lamzede®

  • Generic: velmanase alfa

  • Indication: enzyme replacement therapy for alpha-mannosidosis

R

• Retavase®

  • Generic: reteplase

  • Indication: thrombolytic therapy in acute myocardial infarction

Z

• Zyflo®

• Generic: zileuton

• Indication: leukotriene inhibitor for asthma maintenance